Nos publications > > Articles > 2017

Real-world costs and outcomes in metastatic renal cell carcinoma patients treated by targeted therapies : a cohort study from the French health insurance database.

Lien vers la publication

Maroun R, Fleury L, Nachbaur G, Maunoury F, Vanhille JL, Durand-Zaleski I.

Curr Med Res Opin. 2017 Jul

Dernière mise à jour le 29/08/2017